Jazz Pharmaceuticals
JAZZ
#1420
Rank
A$22.60 B
Marketcap
A$352.21
Share price
3.74%
Change (1 day)
71.84%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2026 (TTM): A$1.06 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are A$4.60 Billion. In 2025 the company made an earning of -A$0.91 Billion a decrease over its 2024 earnings that were of A$0.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$1.06 B-217%
2025 -A$0.91 Billion-233.49%
2024 A$0.68 B57.87%
2023 A$0.43 B-179.92%
2022 -A$0.54 Billion230.37%
2021 -A$0.17 Billion-141.02%
2020 A$0.39 B-39.45%
2019 A$0.65 B-14.2%
2018 A$0.76 B20.03%
2017 A$0.63 B-17.15%
2016 A$0.77 B22.14%
2015 A$0.63 B187.64%
2014 A$0.21 B-50.79%
2013 A$0.44 B73.63%
2012 A$0.25 B41.69%
2011 A$0.18 B116.61%
2010 A$83.57 M262.77%
2009 A$23.03 M-111.33%
2008 -A$0.21 Billion1.31%
2007 -A$0.21 Billion77.8%
2006 -A$0.12 Billion36.59%
2005 -A$82.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$18.28 B 1,637.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
A$3.03 B 188.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-A$3.46 Billion-428.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$2.32 B 120.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel